# Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

> **NCT00321113** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 142 (actual)

## Conditions studied

- KIDNEY TRANSPLANTATION

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** steroids

## Key facts

- **NCT ID:** NCT00321113
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321113, "Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00321113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*